Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Focus Financial Network Inc.

Focus Financial Network Inc. decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 23.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 770 shares of the biotechnology company’s stock after selling 230 shares during the quarter. Focus Financial Network Inc.’s holdings in Axon Enterprise were worth $458,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in AXON. CWM LLC lifted its holdings in shares of Axon Enterprise by 1.3% during the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after acquiring an additional 36 shares in the last quarter. Vontobel Holding Ltd. increased its stake in Axon Enterprise by 58.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 4,066 shares of the biotechnology company’s stock worth $1,625,000 after buying an additional 1,503 shares during the period. Wolff Wiese Magana LLC purchased a new stake in Axon Enterprise during the 3rd quarter worth $237,000. SPC Financial Inc. increased its stake in Axon Enterprise by 2.2% during the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock worth $708,000 after buying an additional 38 shares during the period. Finally, Bleakley Financial Group LLC increased its stake in Axon Enterprise by 7.9% during the 3rd quarter. Bleakley Financial Group LLC now owns 1,507 shares of the biotechnology company’s stock worth $602,000 after buying an additional 110 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $664.70 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $260.27 and a fifty-two week high of $698.67. The firm has a 50-day simple moving average of $623.30 and a 200 day simple moving average of $503.70. The company has a market cap of $50.68 billion, a PE ratio of 171.76, a P/E/G ratio of 6.79 and a beta of 1.05.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. JMP Securities lifted their price target on shares of Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $542.15.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the sale, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock valued at $5,631,561 in the last quarter. Insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.